TrismusNCT02094690
Physiotherapy for Radiation-induced Trismus
A study testing Therabite and Hyperboloid in people with Trismus and Radiation-induced Fibrosis, run by Federal University of Health Science of Porto Alegre at 1 site in Brazil.
Trial summary
The purpose of this study is to assess the effect of two protocols of physiotherapeutic exercises in the maintenance and/or increase of the mandibular range of movement in patients suffering from head and neck cancer (HNC) who are undergoing radiotherapy. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Trismus, Radiation-induced Fibrosis
- What is being tested?
- Therabite and Hyperboloid
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteBrazil
- Study dates
- Jun 2013to Jun 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- signature of the Informed Consent Form;
- both male and female individuals, aged 18 or over;
- patients with a diagnosis of anatomopathological mouth and/or pharyngeal cancer;
- patients who have undergone radiotherapy only, or radiotherapy combined with surgery and/or chemotherapy;
- patients who have one or more muscles of mastication in the radiation field, and;
- patients who have scored more than 60% in the Karnofsky Performance Status.
Who cannot join
- those with facial paralysis, trigeminal neuralgia and/or herpes zoster;
- patients undergoing brachytherapy;
- patients undergoing physiotherapy intervention.
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Hospital Santa Rita - Santa Casa de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90.020-090
About this study
Official title: Prophylactic Physiotherapy Development Of Radiation-Induced Trismus In Patients With Head And Neck Cancer: Randomized Controlled Clinical Trial
The purpose of this study is to assess the effect of two protocols of physiotherapeutic exercises in the maintenance and/or increase of the mandibular range of movement in patients suffering from head and neck cancer (HNC) who are undergoing radiotherapy.
Read the detailed description
Because of contradictory data in the literature with regards to the efficiency of physiotherapeutic techniques to prevent and treat radiation-induced trismus, we believe there is a need to better investigate the efficiency and the quality of life resulting from the different prophylactic physiotherapeutic techniques for radiation-induced trismus in patients with HNC. After the conclusion of this research, we hope to suggest a suitable physiotherapeutic protocol to prevent this complication thereby allowing for an improvement in patients' quality of life.
Data collection:
All patients who begin Radiotherapy the Hospital will attend a group meeting with the nursing staff in order to receive information about their treatment. In the groups, we will identify patients who meet the study inclusion criteria and explain the Informed Consent Form. After we explain to patients their rights in accordance with resolution 196/96 of the National Health Council and they agree to take part by signing the consent form, we will begin gathering data.
The gathering of data will be done always by the same researcher, who will assess the patient twice; the first assessment will take place before the onset of radiotherapy treatment, preferably on the day that the patient undergoes simulation (baseline), the second assessment will take place immediately after the last session of radiotherapy (post radiotherapy), third assessment will take a place six months after radiotherapy and the late follow-up one year after the radiotherapy treatment. Each patient will have a different total duration of radiotherapy regarding the dosage of radiation and type of tumor. It is expected that the total duration of radiation will vary between 45 to 60 days.
Prior to that, all patients will be interviewed on a one-to-one basis in the premises of the Radiotherapy Service to provide their medical history. Other information such as tumor site, neoplastic histological type, staging,radiation field, dosage for each radiotherapy session, bilateral or unilateral presentation and aim of treatment (palliative or curative) will be taken from the patient's hospital records.
The physical examination will take place in accordance with the guidelines and specifications of the Research Diagnostic Criteria for Temporomandibular Disorders - RDC/TMD, which evaluates variables such as the range of motion of the temporomandibular joint (TMJ), joint sounds and level of pain when pressed by the fingers and to the mastication muscles. RDC/TMD is widely used in the scientific and clinical practice for assessment of temporomandibular dysfunction, as it has been officially translated into 18 languages, including Portuguese.
After recording the patient´s medical history and carrying out a physical examination, the patient will receive the University of Washington Quality of Life Questionnaire, version 4.
After undergoing assessment, patients will be given instructions about the physiotherapy exercises to be performed with the aid of an assistant physiotherapist. Patients will be randomly placed into 3 Groups.
The control group will not receive any of the protocols tested in the study, but together with the other groups, will receive the regular treatment offered by the institution, which is made up of guidance and advice given by the hospital´s nursing team about the radiotherapy treatment.
In order to assess patients' compliance with the protocol, they will be given a training calendar at baseline in order to record their compliance or not with the regime. Completed calendars will be collected at post radiotherapy.
Sample Size:
The sample size has been determined with the aid of the software PEPI (Programs for Epidemiologists) version 4.0 and based in the works of Tang et al.
(2011) and Buchbinder et al. (1993). In order to achieve a significance of 5%, a power of 90% and an effect size of one standard deviation amongst the groups, we have obtained a total of at least 23 patients in each of the 3 groups, with a grand total of 69 patients.
Randomization:
The randomization will be done by the software PEPI (Programs for Epidemiologists), subcategory RANDOM, which will draw the random numbers in each group. The allocation will be kept secret by the existence of a randomization list which will be kept in an isolated venue. The sequence of numbers to be used in the randomization will be kept confidential and will only be disclosed at the exact moment when intervention begins.
Statistical Analysis:
The quantitative variables will be described by standard deviation and mean while the qualitative variables will be described by absolute and relative frequency.
The Kolmogorov-Smirnov Test will be used to verify data normality. In order to compare intra and inter groups, the two-way Variable Analysis (ANOVA) for repeated measures with Bonferroni post-hoc test will be applied. In order to compare the means amongst the groups at the baseline, the one-way Analysis of Variance (ANOVA) with Tukey´s post-hoc will be used. If asymmetry is detected, we will apply the Kruskal-Wallis test supplemented by Mann-Whitney test.
In order to compare distribution, the Pearson chi-square test supplemented by the adjusted residuals will be applied. In order to compare the domains of Quality of Life, the Analysis of Variance (ANOVA) with Bonferroni post-hoc will be used for repeated measurements.
In order to assess the correlation between continuous variables, the Pearson linear correlation test will be used. If asymmetry is detected, the Spearman correlation will be applied.
The significance level adopted will be that of 5% (p<0,05) and the analyses will be done using the software SPSS (Statistical Package for the Social Sciences) version 17.0.
- Conditions
- Trismus, Radiation-induced Fibrosis
- Being tested
- Therabite, Hyperboloid
- Keywords
- head and neck neoplasms, radiotherapy, physical therapy, trismus
- Medical subject headings
- Trismus, Radiation Fibrosis Syndrome, Head and Neck Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TherabiteDevice
10 repetitions holding Therabite for 30 seconds. The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed).
HyperboloidDevice
5 min of bilateral mastication alternated with hyperboloid. The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed).
| Study group | Role | What they receive |
|---|---|---|
| Device Hyperboloid | Active comparator | 5 min of bilateral mastication alternated with the device hyperboloid The exercises should begin one day before the onset of Radiotherapy (RT) and kept until the end of RT.
Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). Receives: Device: Hyperboloid |
| Device Therabite | Active comparator | * 10 repetitions holding the device Therabite for 30 seconds
* 5 min of bilateral mastication alternated with the device hyperboloid The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT.
Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). Receives: Device: Therabite; Device: Hyperboloid |
| Control | No intervention | The control group (GEC) will not receive any of the protocols tested in the study, but together with the other groups, will receive the regular treatment offered by the institution, which is made up of guidance and advice given by the hospital´s nursing team about the radiotherapy treatment. Currently, patients do not receive any information as far as trismus is concerned. |
What is being measured
The primary outcome is the main question the study is designed to answer.
mouth opening in millimeters (mm)
Mouth opening will be assessed before (baseline) and after total radiotherapy treatment (post radiotherapy) in order to establish if there have been any changes resulting from radiotherapy. The measure of mouth opening will be conducted with a pachymeter placed at the incisal edge of the superior and inferior incisor teeth. The maximal vertical distance, in millimeters, between the superior and inferior incisor teeth will be considered the total mouth opening of the patient.
Measured: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Secondary outcomes (3)
Quality of life
Quality of life will be assessed by applying the UW-QOL Questionnaire, version 4, which is validated for the Brazilian population
Measured: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Performance status
Perfomance status will be assessed by applying Karnofsky Perfirmance Status
Measured: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Mucositis
Mucositis will be graduated through World and Health Organization scale
Measured: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Mar 2014 (estimated)
- Study startJun 2013
- Primary completionMay 2014
- Study completionJun 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TrismusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Federal University of Health Science of Porto Alegre
- Sponsor type
- University, hospital or other
- Collaborators
- Irmandade Santa Casa de Misericórdia de Porto Alegre
- Responsible party
- Principal investigator, Karoline Camargo Bragante, Federal University of Health Science of Porto Alegre
- Investigators
- Geraldo P. Jotz, Ph.D, Study director, Federal University of Rio Grande do Sul - UFRGS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02094690
- Sponsor's protocol ID
- 259.691
- Status last verified
- Jan 2019
- First submitted
- 12 Jul 2013
- Last updated
- 4 Jan 2019
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 4 Jan 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prophylactic Physiotherapy Development Of Radiation-Induced Trismus In Patients With Head And Neck Cancer: Randomized Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT02094690
- Acronym / sponsor ID
- 259.691
- Conditions
- Trismus, Radiation-induced Fibrosis
- Keywords
- head and neck neoplasms, radiotherapy, physical therapy, trismus
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Federal University of Health Science of Porto AlegreUniversity, hospital or other
- Collaborators
- Irmandade Santa Casa de Misericórdia de Porto Alegre
- Study start
- Jun 2013
- Primary completion
- May 2014 (actual)
- Study completion
- Jun 2017 (actual)
- First posted
- 24 Mar 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to assess the effect of two protocols of physiotherapeutic exercises in the maintenance and/or increase of the mandibular range of movement in patients suffering from head and neck cancer (HNC) who are undergoing radiotherapy.
Detailed description
Because of contradictory data in the literature with regards to the efficiency of physiotherapeutic techniques to prevent and treat radiation-induced trismus, we believe there is a need to better investigate the efficiency and the quality of life resulting from the different prophylactic physiotherapeutic techniques for radiation-induced trismus in patients with HNC. After the conclusion of this research, we hope to suggest a suitable physiotherapeutic protocol to prevent this complication thereby allowing for an improvement in patients' quality of life.
Data collection:
All patients who begin Radiotherapy the Hospital will attend a group meeting with the nursing staff in order to receive information about their treatment. In the groups, we will identify patients who meet the study inclusion criteria and explain the Informed Consent Form. After we explain to patients their rights in accordance with resolution 196/96 of the National Health Council and they agree to take part by signing the consent form, we will begin gathering data.
The gathering of data will be done always by the same researcher, who will assess the patient twice; the first assessment will take place before the onset of radiotherapy treatment, preferably on the day that the patient undergoes simulation (baseline), the second assessment will take place immediately after the last session of radiotherapy (post radiotherapy), third assessment will take a place six months after radiotherapy and the late follow-up one year after the radiotherapy treatment. Each patient will have a different total duration of radiotherapy regarding the dosage of radiation and type of tumor. It is expected that the total duration of radiation will vary between 45 to 60 days.
Prior to that, all patients will be interviewed on a one-to-one basis in the premises of the Radiotherapy Service to provide their medical history. Other information such as tumor site, neoplastic histological type, staging,radiation field, dosage for each radiotherapy session, bilateral or unilateral presentation and aim of treatment (palliative or curative) will be taken from the patient's hospital records.
The physical examination will take place in accordance with the guidelines and specifications of the Research Diagnostic Criteria for Temporomandibular Disorders - RDC/TMD, which evaluates variables such as the range of motion of the temporomandibular joint (TMJ), joint sounds and level of pain when pressed by the fingers and to the mastication muscles. RDC/TMD is widely used in the scientific and clinical practice for assessment of temporomandibular dysfunction, as it has been officially translated into 18 languages, including Portuguese.
After recording the patient´s medical history and carrying out a physical examination, the patient will receive the University of Washington Quality of Life Questionnaire, version 4.
After undergoing assessment, patients will be given instructions about the physiotherapy exercises to be performed with the aid of an assistant physiotherapist. Patients will be randomly placed into 3 Groups.
The control group will not receive any of the protocols tested in the study, but together with the other groups, will receive the regular treatment offered by the institution, which is made up of guidance and advice given by the hospital´s nursing team about the radiotherapy treatment.
In order to assess patients' compliance with the protocol, they will be given a training calendar at baseline in order to record their compliance or not with the regime. Completed calendars will be collected at post radiotherapy.
Sample Size:
The sample size has been determined with the aid of the software PEPI (Programs for Epidemiologists) version 4.0 and based in the works of Tang et al.
(2011) and Buchbinder et al. (1993). In order to achieve a significance of 5%, a power of 90% and an effect size of one standard deviation amongst the groups, we have obtained a total of at least 23 patients in each of the 3 groups, with a grand total of 69 patients.
Randomization:
The randomization will be done by the software PEPI (Programs for Epidemiologists), subcategory RANDOM, which will draw the random numbers in each group. The allocation will be kept secret by the existence of a randomization list which will be kept in an isolated venue. The sequence of numbers to be used in the randomization will be kept confidential and will only be disclosed at the exact moment when intervention begins.
Statistical Analysis:
The quantitative variables will be described by standard deviation and mean while the qualitative variables will be described by absolute and relative frequency.
The Kolmogorov-Smirnov Test will be used to verify data normality. In order to compare intra and inter groups, the two-way Variable Analysis (ANOVA) for repeated measures with Bonferroni post-hoc test will be applied. In order to compare the means amongst the groups at the baseline, the one-way Analysis of Variance (ANOVA) with Tukey´s post-hoc will be used. If asymmetry is detected, we will apply the Kruskal-Wallis test supplemented by Mann-Whitney test.
In order to compare distribution, the Pearson chi-square test supplemented by the adjusted residuals will be applied. In order to compare the domains of Quality of Life, the Analysis of Variance (ANOVA) with Bonferroni post-hoc will be used for repeated measurements.
In order to assess the correlation between continuous variables, the Pearson linear correlation test will be used. If asymmetry is detected, the Spearman correlation will be applied.
The significance level adopted will be that of 5% (p<0,05) and the analyses will be done using the software SPSS (Statistical Package for the Social Sciences) version 17.0.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Device Hyperboloid | Active comparator | Device: Hyperboloid5 min of bilateral mastication alternated with the device hyperboloid The exercises should begin one day before the onset of Radiotherapy (RT) and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). |
| Device Therabite | Active comparator | Device: Therabite, Device: Hyperboloid* 10 repetitions holding the device Therabite for 30 seconds * 5 min of bilateral mastication alternated with the device hyperboloid The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). |
| Control | No intervention | –The control group (GEC) will not receive any of the protocols tested in the study, but together with the other groups, will receive the regular treatment offered by the institution, which is made up of guidance and advice given by the hospital´s nursing team about the radiotherapy treatment. Currently, patients do not receive any information as far as trismus is concerned. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- signature of the Informed Consent Form;
- both male and female individuals, aged 18 or over;
- patients with a diagnosis of anatomopathological mouth and/or pharyngeal cancer;
- patients who have undergone radiotherapy only, or radiotherapy combined with surgery and/or chemotherapy;
- patients who have one or more muscles of mastication in the radiation field, and;
Key exclusion criteria (3 listed)
- those with facial paralysis, trigeminal neuralgia and/or herpes zoster;
- patients undergoing brachytherapy;
- patients undergoing physiotherapy intervention.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Therabite10 repetitions holding Therabite for 30 seconds. The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). | Device | Device Therabite |
| Hyperboloid5 min of bilateral mastication alternated with hyperboloid. The exercises should begin one day before the onset of Radiotherapy and kept until the end of RT. Repeated 4x a day (after breakfast, lunch, dinner and before going to bed). | Device | Device Hyperboloid, Device Therabite |
Primary outcome
mouth opening in millimeters (mm)
Time frame: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Mouth opening will be assessed before (baseline) and after total radiotherapy treatment (post radiotherapy) in order to establish if there have been any changes resulting from radiotherapy. The measure of mouth opening will be conducted with a pachymeter placed at the incisal edge of the superior and inferior incisor teeth. The maximal vertical distance, in millimeters, between the superior and inferior incisor teeth will be considered the total mouth opening of the patient.
3 secondary outcomes
Quality of life
Time frame: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Performance status
Time frame: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Mucositis
Time frame: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jan 2019.
- RDC/TMD is widely used in the scientific and clinical practice for assessment of temporomandibular dysfunctionLink provided by the sponsor.
Related trials for Trismus
Recruiting
Swallowing Rehabilitation Program for Head and Neck Tumor Patients
Head and Neck Cancer (H&N)
RecruitingPhase 2
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
Throat Carcinoma
Recruiting
Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus
Head and Neck Cancer, Trismus
Recruiting
Comparison of PRF and Corticosteroids in Impacted Third Molar Surgery
Impacted Mandibular Third Molar Extraction, Impacted Lower Third Molar
Not yet recruiting
Management of Postoperative Complications After Mandibular Third Molar Extraction Using Submucosal Triamcinolone Injection, Kinesiology Taping, and Standard Care
Trismus, Edema
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Geraldo P. Jotz, Ph.D study director
Federal University of Rio Grande do Sul - UFRGS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Therabite and Hyperboloid in people with Trismus and Radiation-induced Fibrosis, run by Federal University of Health Science of Porto Alegre at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mouth opening in millimeters (mm) (time frame: baseline (before radiotherapy), post radiotherapy (after the end of radiotherapy), 6 months follow-up and one year follow-up It is expected that the total duration of radiation will vary between a 45 to 60 days.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2019.